Skip to content
★ Sign in to follow
生展

生展 Stock: price and insider trades · Taiwan

TW·Mcap NT$2.1BHealth Care

生展: what insiders have been doing

We have very little insider data for 生展 so far: the most recent filing dates from 12 September 2016. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by TWSE / TPEx (MOPS). They describe what insiders did and are not a recommendation.

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 1,980 of 26,911 companies
76.5
score / 100
Value
87
Quality
66
FCF yld11%
Earn yld13%
EV/EBITDA5.3x
ROE9.8%
Gross mgn34%
Net mgn13%
Debt/EBITDA0.7x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

NT$79
Analyst consensus
·
Income statement
RevenueNT$2.1B
Gross profitNT$723.6M34% margin
EBITDANT$461.8M22% margin
Net incomeNT$271.6M11.0% margin
Valuation
PER (trailing)9.7x
P/Book0.9x
Beta0.13
Balance sheet & cash
Market capNT$2.1B
Total debtNT$315.6M
Free Cash FlowNT$243.1M
Debt / Equity7%
Profitability & ownership
ROE9.8%
ROA5.3%
% insiders63.5%
% institutions4.7%
Last declaration on 12 September 2016
Declarations1 total
  • ●
    Related company / holdingExecutives
    0MOPS
    175,000 sharesShareTPExTWMOPS:8279:105/09/12:生達化學製藥股份有限公司:17ecydb

1 of 1 declaration

About 生展

生展 is a company listed on the XTAI market, specializing in the development and management of innovative projects. It focuses on creating sustainable and efficient solutions across various sectors.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations